This week, GOLD speaks to Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva Pharmaceuticals, about unlocking further potential in developed markets, the impact of COVID-19 on MSL KPIs, and building medical affairs teams that are fit for the future.
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.